Community post jraverhoff Chronic Myeloid Leukemia Discussion • August 4 MECOM Rearrangement Has anyone seen data that suggest third generation TK Inhibitors have the same efficacy as second generation TK Inhibitors when treating CML with MECOM Rearrangement? React Comment